Autoimmune & Systemic Inflammation Protocol
Autoimmune & Systemic Inflammation Protocol framework focused on consistent execution, practical monitoring, and safer progression.
A comprehensive protocol targeting autoimmune dysregulation and chronic systemic inflammation using peptides that modulate immune checkpoints, reduce cytokine storms, and restore peripheral tolerance.
Who it's for
Use this as an educational framework with clinical oversight. Keep timing consistent, track response daily, and change one variable at a time after trend review. Pair protocol use with sleep, nutrition, and recovery fundamentals.
Free Peptide Guide
Autoimmune & Systemic Inflammation Protocol Protocol PDF
Schedule template, practical checkpoints, common mistakes, and safety guidance in one quick reference.
Free access. No spam. This form sends the shared peptide guide that is live today.
Protocol at a Glance
Cycle Duration
12 weeks on, 4 weeks off; can repeat quarterly
Target Audience
Individuals with autoimmune conditions, chronic inflammation, or elevated inflammatory biomarkers
| Compound | Dose | Frequency |
|---|---|---|
| Thymosin Alpha-1 Core immune regulator; restores T-regulatory cell function | 1.5 mg | 3x/week |
| ARA-290 Activates TNFR2 innate repair pathway; potent anti-inflammatory | 4 mcg/kg | Daily |
| BPC-157 Gut barrier restoration; modulates mucosal immunity | 250 mcg | Twice daily |
| LL-37 Antimicrobial peptide with immunomodulatory properties | 1-2 mg | 2x/week |
| VIP Vasoactive intestinal peptide; suppresses Th1/Th17 cytokine cascade | 25 mcg | Daily |
Free Peptide Guide
Autoimmune & Systemic Inflammation Protocol Protocol PDF
Schedule template, practical checkpoints, common mistakes, and safety guidance in one quick reference.
Free access. No spam. This form sends the shared peptide guide that is live today.
Daily Schedule
Morning
Baseline review and first execution window
Log sleep, energy, and tolerance; complete planned Thymosin Alpha-1 timing if scheduled.
Midday
Adherence and symptom check
Review hydration, workload, and side effects before any changes.
Evening
Recovery closeout and next-day setup
Record outcomes, maintain schedule consistency, and prepare next-day protocol.
Safety
- Escalating side effects or new concerning symptoms require prompt clinical review.
- Avoid abrupt multi-compound changes during unstable periods.
- Maintain regular follow-up with a licensed clinician throughout the cycle.
Not appropriate for unsupervised use or as a replacement for diagnosis and medical care. Use only within a clinician-guided plan.
Who should avoid
- Anyone using this protocol without qualified medical supervision
- People with unstable medical or psychiatric conditions without specialist guidance
- Pregnant or breastfeeding individuals unless explicitly cleared by a physician
Common Mistakes
Changing multiple variables at once
Why it matters: This makes it hard to identify what improved outcomes versus what increased side effects.
How to fix: Keep one-variable changes per review cycle and log response for several days.
Ignoring adherence and recovery fundamentals
Why it matters: Protocol effectiveness drops when sleep, nutrition, and routine consistency are unstable.
How to fix: Protect daily anchors first, then optimize protocol details gradually.
FAQ
How long should Autoimmune & Systemic Inflammation Protocol run before reassessment?
A common window is 12 weeks on, 4 weeks off; can repeat quarterly, with periodic review of tolerance and objective trends.
Can I increase complexity quickly for faster results?
Usually no. Safer optimization comes from staged changes and clear tracking.
What should I track each day?
Track schedule adherence, symptoms, sleep quality, and any adverse effects in one log.
Key Takeaways
- Consistency with Thymosin Alpha-1 + ARA-290 execution matters more than frequent protocol changes.
- Single-variable adjustments improve safety and decision quality.
- Objective daily tracking supports better long-term outcomes.
Why This Stack Works
Thymosin Alpha-1 re-educates T-cell subsets and restores immune tolerance, while ARA-290 activates innate repair receptors to suppress pro-inflammatory cytokines. BPC-157 modulates gut-associated lymphoid tissue and reduces intestinal permeability. LL-37 serves as an immune modulator with broad antimicrobial and regulatory properties. VIP acts as a master immunomodulatory neuropeptide suppressing Th1/Th17 pathways.
Clinical Research
No clinical references were provided for this stack yet.
More Immune Support Stacks
Ankylosing Spondylitis & Axial Spondyloarthropathy Protocol
An adjunctive protocol for individuals with ankylosing spondylitis and axial spondyloarthropathy, targeting the IL-17/IL-23-driven enthesitis, progressive syndesmophyte formation, and the TNF-driven inflammatory cascade that cause irreversible spinal fusion.
Ankylosing Spondylitis & Axial Spondyloarthropathy Protocol
Anti-inflammatory and joint-protective peptide protocol for ankylosing spondylitis targeting spinal inflammation, syndesmophyte prevention, and preservation of spinal mobility.
Crohn's Disease & IBD Management Protocol
Peptide-based protocol targeting intestinal inflammation, barrier repair, and mucosal immune regulation for Crohn's disease and ulcerative colitis management.
Medical disclaimer: This protocol is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any peptide protocol.
Free Peptide Guide
Autoimmune & Systemic Inflammation Protocol Protocol PDF
Schedule template, practical checkpoints, common mistakes, and safety guidance in one quick reference.
Free access. No spam. This form sends the shared peptide guide that is live today.